6533b82efe1ef96bd1292ff6

RESEARCH PRODUCT

Cancer of Exocrine Pancreas

Marc PeetersJuan L. IovannaAntonio RussoAlbert J. Ten TijeDaniele FanaleG. MadoniaAntonio Galvano

subject

Oncologymedicine.medical_specialtybusiness.industryFOLFIRINOXmedicine.medical_treatmentCancerDiseasemedicine.diseaseInternal medicinePancreatic cancerPancreatectomyMedicineAdenocarcinomaCA19-9Stage (cooking)business

description

Pancreatic adenocarcinoma represents today a real challenge for oncologists all around the world: it is the 11th most common cancer worldwide, and the 7th deadliest, with a steadily increasing number of new cases every year. Many risk factors, both environmental and genetic, have been identified, the most important of which are excessive body weight, diabetes, and smoking; also, new diagnostic techniques, such as spiral TC, MRCP, and EUS, have improved the ability to diagnose this disease at an early stage. Nevertheless, pancreatic cancer is a silent disease, with few or no symptoms and signs until late stages: the vast majority of patients are inoperable at the time of diagnosis, with either metastatic or locally advanced disease.

https://doi.org/10.1007/978-3-030-56051-5_40